Literature DB >> 4214687

The metabolic fate of cyclophosphamide.

A R Torkelson, J A LaBudde, J H Weikel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214687     DOI: 10.3109/03602537408993740

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  11 in total

1.  [Blood-brain barrier and the penetration of cytostatic drugs].

Authors:  C Unger; H Eibl; H W von Heyden; B Krisch; G A Nagel
Journal:  Klin Wochenschr       Date:  1985-06-18

2.  Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.

Authors:  J Ellenberger; G Mohn
Journal:  Arch Toxicol       Date:  1975       Impact factor: 5.153

Review 3.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.

Authors:  F D Juma; H J Rogers; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

5.  Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Irritancy of cyclophosphamide-derived aldehydes (acrolein, chloracetaldehyde) and their effect on lymphocyte distribution in vivo: protective effect of thiols and bisulphite ions1).

Authors:  M Whitehouse; F W Beck
Journal:  Agents Actions       Date:  1975-12

Review 7.  Tumour endoproteases: the cutting edge of cancer drug delivery?

Authors:  J M Atkinson; C S Siller; J H Gill
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  Use of an indicator sequence of human DNA to study DNA damage by methylbis(2-chloroethyl)amine.

Authors:  S M Grunberg; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture.

Authors:  J R Jeffery; R D Guttmann; B Charpentier
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

10.  Distribution and pharmacokinetics of cyclophosphamide in the rat.

Authors:  M R Talha; H J Rogers; J R Trounce
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.